ncRNA name
hsa_circ_0100181
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
AMPK/mTOR signaling pathway
Cancer name
Acute Myeloid Leukemia
Cancer site
Leukemia
Treatment type
Chemotherapy
Drug
Adriamycin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
CircPAN3 may facilitate AML drug resistance through regulating autophagy and influencing expression of apoptosisrelated proteins, while AMPK/mTOR signaling plays a key role in the regulation of circPAN3 on autophagy.
Tissue resource
human acute myeloid leukemia cells THP-1
human acute myeloid leukemia cells K562
Experiment
qRT-PCR,Western blot
Institute
American Type Culture Collection
Country
USA
Continent
North American